DiffracTox AB is a contract research organization (CRO) that provides services relating to the Biochemical, Biophysical and Structural analysis of Botulinum neurotoxins.  

DiffracTox AB also has a subsidiary company, ToxoTech AB, that designs and develops novel toxins with improved therapeutic potential.